Welcome to the international HTA database

Showing [23369 Records] Selected Records [0 Hits] [Clear]

Year	Source	Title
2016	Penn Medicine Center for Evidence-based Practice (CEP)	Amiodarone method of administration for treatment of post-operative atrial fibrillation
2016	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Elotuzumab (multiple myeloma) - Addendum to Commission A16-32]
2016	The Regional Health Technology Assessment Centre (HTA-centrum)	Positron emission tomography and computed tomographic imaging prior to radiotherapy for lung cancer
2016	National Institute for Health and Care Excellence (NICE)	Balloon pulmonary angioplasty for chronic thromboembolic pulmonary hypertension. NICE interventional procedures guidance 554
2016	Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA)	Bevacizumab (Avastin®) in addition to standard chemotherapy for the first-line treatment of ovarian cancer
2016	Agency for Healthcare Research and Quality (AHRQ)	Strategies for improving the lives of women aged 40 and above living with HIV/AIDS.
2016	Penn Medicine Center for Evidence-based Practice (CEP)	Pathways for management of refractory epistaxis
2016	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Pembrolizumab (non-small cell lung cancer) - Benefit assessment according to §35a Social Code Book V]
2016	The Regional Health Technology Assessment Centre (HTA-centrum)	Positron emission tomography and computed tomographic imaging prior to radiotherapy for anal cancer
2016	National Institute for Health and Care Excellence (NICE)	Percutaneous interlaminar endoscopic lumbar discectomy for sciatica. NICE interventional procedures guidance 555
2016	NIHR Health Technology Assessment programme	Intraoperative frozen section analysis for the diagnosis of early stage ovarian cancer in women with suspicious pelvic masses
2016	Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA)	Afatinib (Giotrif®) in patients with non-small cell lung cancer (NSCLC) who are refractory to erlotinib/gefitinib and afatinib monotherapy
2016	Penn Medicine Center for Evidence-based Practice (CEP)	Transfusion thresholds in cardiovascular surgery
2016	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Eribulin (liposarcoma) - Addendum A16-31
2016	The Regional Health Technology Assessment Centre (HTA-centrum)	Does salpingectomy reduce the risk of ovarian cancer?
2016	National Institute for Health and Care Excellence (NICE)	Percutaneous transforaminal endoscopic lumbar discectomy for sciatica. NICE interventional procedures guidance 556
2016	Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA)	[Drugs in oncology: an overview of benefit and refund practices in Europe]
2016	Penn Medicine Center for Evidence-based Practice (CEP)	Erythropoiesis stimulating agents for cardiac surgery patients
2016	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Trifluridine/tipiracil (colorectal cancer) - Benefit assessment according to §35a Social Code Book V]
2016	National Institute for Health and Care Excellence (NICE)	Corticosteroid-eluting bioabsorbable stent or spacer insertion during endoscopic sinus surgery to treat chronic rhinosinusitis. NICE interventional procedures guidance 551
2016	NIHR Health Technology Assessment programme	Anticoagulants (extended duration) for prevention of venous thromboembolism following total hip or knee replacement or hip fracture repair
2016	Penn Medicine Center for Evidence-based Practice (CEP)	Clinical risk prediction scales for venous thromboembolism in hospitalized patients
2016	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Measurement of myocardial fractional flow reserve (FFR) in coronary heart disease]
2016	National Institute for Health and Care Excellence (NICE)	Transcutaneous stimulation of the cervical branch of the vagus nerve for cluster headache and migraine. NICE interventional procedures guidance 552
2016	Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA)	[Percutaneous transluminal coronary angioplasty (PTCA) with drug-eluting balloon (DEB). 2nd Update 2016]
2016	Penn Medicine Center for Evidence-based Practice (CEP)	Managing antenatal hypoglycemia in hospitalized pregnant women with diabetes
2016	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Newborn screening for severe combined immunodeficiency (SCID screening)]
2016	National Institute for Health and Care Excellence (NICE)	Endoscopic carbon dioxide laser cricopharyngeal myotomy for relief of oropharyngeal dysphagia. NICE interventional procedures guidance 550
2016	NIHR Horizon Scanning Centre (NIHR HSC)	Oxecam for health monitoring in secure mental health facilities
2016	NIHR Health Services and Delivery Research programme	The INCENTIVE study: a mixed-methods evaluation of an innovation in commissioning and delivery of primary dental care compared with traditional dental contracting
2016	Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA)	[Screening, diagnostics and indication for occupational therapy in children and adolescents with Developmental Coordination Disorders]
2016	Penn Medicine Center for Evidence-based Practice (CEP)	Duration of contact isolation precautions for patients with a history of MRSA infection or colonization
2016	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Saxagliptin + saxagliptin/metformin: Addendum to Commission A16-42 + A16-43]
2016	National Institute for Health and Care Excellence (NICE)	Angioplasty and stenting to treat peripheral arterial disease causing refractory erectile dysfunction. NICE interventional procedures guidance 546
2016	Haute Autorite de sante (HAS)	[Endovascular thrombectomy of intracranial arteries]
2016	NIHR Health Technology Assessment programme	Cognitive-behavioural therapy-based intervention to reduce fear of falling in older people: therapy development and randomised controlled trial - the Strategies for Increasing Independence, Confidence and Energy (STRIDE) study
2016	NIHR Health Technology Assessment programme	The second Randomised Evaluation of the Effectiveness, cost-effectiveness and Acceptability of Computerised Therapy (REEACT-2) trial: does the provision of telephone support enhance the effectiveness of computer-delivered cognitive behaviour therapy? A randomised controlled trial
2016	NIHR Horizon Scanning Centre (NIHR HSC)	Neon EEG for monitoring neonatal seizures
2016	NIHR Health Services and Delivery Research programme	Infant deaths in the UK community following successful cardiac surgery: building the evidence base for optimal surveillance, a mixed-methods study
2016	Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA)	Leadless pacemakers for right ventricle pacing
2016	Penn Medicine Center for Evidence-based Practice (CEP)	Duration of contact isolation precautions for patients with a history of MRSA infection or colonization
2016	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Nivolumab (melanoma): Addendum to Commission A16-35]
2016	Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S)	Resuscitative endovascular balloon occlusion of the aorta (REBOA)
2016	National Institute for Health and Care Excellence (NICE)	Mechanical clot retrieval for treating acute ischaemic stroke. NICE interventional procedures guidance 548
2016	NIHR Health Technology Assessment programme	Evaluating Acupuncture and Standard care for pregnant womEn with BACK pain (EASE BACK): a feasibility and pilot study
2016	Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS)	[Selection of health priorities: criteria, process and strategic framework. Systematic review]
2016	NIHR Horizon Scanning Centre (NIHR HSC)	ReActiv8® implantable device for treating chronic low back pain
2016	NIHR Public Health Research (PHR) programme	Bristol Girls Dance Project: a cluster randomised controlled trial of an after-school dance programme to increase physical activity among 11- to 12-year-old girls
2016	Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA)	Single-step scaffold-based cartilage repair in the knee
2016	Penn Medicine Center for Evidence-based Practice (CEP)	Bedside psychotherapy for depression or anxiety in hospitalized medical-surgical patients
2016	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Measurement of preference in parodontopathy]
2016	National Institute for Health and Care Excellence (NICE)	Normothermic extracorporeal preservation of hearts for transplantation following donation after brainstem death. NICE interventional procedures guidance 549
2016	Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS)	[Guideline for the elaboration and adaptation of rapid health technology assessment reports]
2016	NIHR Horizon Scanning Centre (NIHR HSC)	AVATAR therapy for auditory verbal hallucinations in psychosis
2016	NIHR Horizon Scanning Centre (NIHR HSC)	Blinatumomab (Blincyto) for relapsed or refractory Philadelphia-positive B-precursor acute lymphoblastic leukaemia – second or subsequent line
2016	Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA)	Radiofrequency denervation for sacroiliac and facet joint pain
2016	Norwegian Institute of Public Health (NIPH)	Medicines used for multiple sclerosis. A health technology assessment
2016	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Ibrutinib (chronic lymphocytic leukaemia): Addendum to Commission A16-39]
2016	National Institute for Health and Care Excellence (NICE)	Percutaneous coblation of the intervertebral disc for low back pain and sciatica. NICE interventional procedures guidance 543
2016	Agency for Healthcare Research and Quality (AHRQ)	Total Worker Health®
2016	NIHR Horizon Scanning Centre (NIHR HSC)	myPlan™ test for early-stage lung adenocarcinoma prognosis
2016	NIHR Horizon Scanning Centre (NIHR HSC)	Avelumab for Merkel cell carcinoma – second line
2016	Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA)	Upper airway stimulation for moderate-to-severe sleep apnea
2016	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Sofosbuvir/velpatasvir (chronic hepatitis C) - Addendum to Commission A16-48]
2016	National Institute for Health and Care Excellence (NICE)	Percutaneous electrothermal treatment of the intervertebral disc annulus for low back pain and sciatica. NICE interventional procedures guidance 544
2016	NIHR Health Technology Assessment programme	PLEASANT: Preventing and Lessening Exacerbations of Asthma in School-age children Associated with a New Term a cluster randomised controlled trial and economic evaluation
2016	NIHR Public Health Research (PHR) programme	Community pharmacy interventions for public health priorities: a systematic review of community pharmacy-delivered smoking, alcohol and weight management interventions
2016	NIHR Horizon Scanning Centre (NIHR HSC)	Methoxyflurane (Penthrox) for emergency relief of moderate to severe pain
2016	Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA)	Magnetic sphincter augmentation device (MSAD) in patients with gastroesophageal reflux disease (GERD)
2016	National Institute for Health and Care Excellence (NICE)	Percutaneous intradiscal radiofrequency treatment of the intervertebral disc nucleus for low back pain. NICE interventional procedures guidance 545
2016	NIHR Horizon Scanning Centre (NIHR HSC)	CPX-351 (VYXEOS) for elderly patients with newly diagnosed acute myeloid leukaemia – first line
2016	Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA)	Obinutuzumab (Gazyvaro®) in combination with bendamustine for the treatment of relapsed/refractory follicular lymphoma (FL)
2016	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Opicapone (Parkinson disease) - Benefit assessment according to §35a Social Code Book V]
2016	The Federal Joint Committee (G-BA)	[Pharmaceutical Directive/Annex XII: Ataluren (expiry of the deadline)]
2016	NIHR Horizon Scanning Centre (NIHR HSC)	Carfilzomib (Kyprolis) in combination with dexamethasone for relapsed multiple myeloma – second line
2016	NIHR Horizon Scanning Centre (NIHR HSC)	ATIR101 for patients with haematological malignancy who are candidates for haematopoietic stem cell transplantation – adjunctive therapy
2016	Norwegian Institute of Public Health (NIPH)	Health technology assessment of four drugs for patients with metastatic castration resistant prostate cancer
2016	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Ceritinib (lung cancer): benefit assessment according to §35a Social Code Book V; expiry of the decision
2016	NIHR Horizon Scanning Centre (NIHR HSC)	Buparlisib with fulvestrant for postmenopausal women with metastatic oestrogen-receptor positive, HER2 negative breast cancer – third line
2016	NIHR Horizon Scanning Centre (NIHR HSC)	Carfilzomib (Kyprolis) in combination with melphalan and prednisone for multiple myeloma – first line
2016	NIHR Health Technology Assessment programme	Palbociclib for treating metastatic, hormone receptor-positive, HER2-negative breast cancer [ID915]
2016	Norwegian Institute of Public Health (NIPH)	[Non-invasive prenatal testing (NIPT) for foetal sex determination]
2016	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Crizotinib (lung cancer) - Benefit assessment according to §35a Social Code Book V]
2016	NIHR Horizon Scanning Centre (NIHR HSC)	Reolysin for advanced or metastatic pancreatic cancer – first line
2016	NIHR Horizon Scanning Centre (NIHR HSC)	Dabrafenib (Tafinlar) with trametinib (Mekinist) for BRAF V600 mutation positive melanoma – adjuvant therapy
2016	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Lenvatinib (renal cell carcinoma): benefit assessment according to §35a Social Code Book V]
2016	NIHR Horizon Scanning Centre (NIHR HSC)	Irinotecan-eluting beads (DC Bead, DC Bead M1 and DC Bead Lumi) for liver metastases secondary to colorectal cancer
2016	NIHR Horizon Scanning Centre (NIHR HSC)	Lifitegrast for dry eye disease
2016	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Ibrutinib (chronic lymphocytic leukaemia): benefit assessment according to §35a Social Code Book V]
2016	NIHR Horizon Scanning Centre (NIHR HSC)	Idelalisib in combination with bendamustine and rituximab for indolent non-Hodgkin lymphoma – second line
2016	NIHR Horizon Scanning Centre (NIHR HSC)	Nivolumab (Opdivo) for gastric and gastroesophageal junction adenocarcinoma – third and fourth line
2016	NIHR Horizon Scanning Centre (NIHR HSC)	rhPTH (Natpar) for hypoparathyroidism – adjunctive therapy
2016	NIHR Horizon Scanning Centre (NIHR HSC)	Ozanimod for relapsing remitting multiple sclerosis
2016	NIHR Horizon Scanning Centre (NIHR HSC)	C3BS-CQR-1 (C-Cure) for heart failure secondary to ischaemic cardiomyopathy
2016	NIHR Horizon Scanning Centre (NIHR HSC)	Siponimod for secondary progressive multiple sclerosis
2016	NIHR Horizon Scanning Centre (NIHR HSC)	Veliparib with carboplatin and paclitaxel for early-stage triple negative breast cancer ─ neoadjuvant therapy
2016	NIHR Health Technology Assessment programme	ImmunoCAP® ISAC and Microtest for multiplex allergen testing in people with difficult to manage allergic disease: a systematic review and cost analysis
2016	NIHR Horizon Scanning Centre (NIHR HSC)	Sofosbuvir, GS-9857 and velpatasvir triple therapy for chronic hepatitis C
2016	NIHR Health Services and Delivery Research programme	Transforming community health services for children and young people who are ill: a quasi-experimental evaluation
2016	NIHR Health Technology Assessment programme	TRAPEZE: a randomised controlled trial of the clinical effectiveness and cost-effectiveness of chemotherapy with zoledronic acid, strontium-89, or both, in men with bony metastatic castration-refractory prostate cancer